156 related articles for article (PubMed ID: 8513508)
1. Differential regulation of group A streptococcal peptidoglycan-polysaccharide (PG-APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG-APS-induced arthritis.
Bristol LA; Durum SK; Eisenberg SP
Cell Immunol; 1993 Jun; 149(1):130-43. PubMed ID: 8513508
[TBL] [Abstract][Full Text] [Related]
2. Bone-resorbing activity is expressed by rat macrophages in response to arthropathic streptococcal cell wall polymers.
Bristol-Rothstein LA; Schwab JH
Inflammation; 1992 Oct; 16(5):485-96. PubMed ID: 1428123
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide.
Stimpson SA; Dalldorf FG; Otterness IG; Schwab JH
J Immunol; 1988 May; 140(9):2964-9. PubMed ID: 3283241
[TBL] [Abstract][Full Text] [Related]
4. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.
McCall RD; Haskill S; Zimmermann EM; Lund PK; Thompson RC; Sartor RB
Gastroenterology; 1994 Apr; 106(4):960-72. PubMed ID: 8144001
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
Phadke K; Carlson DG; Gitter BD; Butler LD
J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive macrophages induced by arthropathic peptidoglycan-polysaccharide polymers from bacterial cell walls.
Regan DR; Cohen PL; Cromartie WJ; Schwab JH
Clin Exp Immunol; 1988 Dec; 74(3):365-70. PubMed ID: 3069253
[TBL] [Abstract][Full Text] [Related]
7. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis.
Allen JB; Wong HL; Costa GL; Bienkowski MJ; Wahl SM
J Immunol; 1993 Oct; 151(8):4344-51. PubMed ID: 8409406
[TBL] [Abstract][Full Text] [Related]
8. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis.
Chen W; Jin W; Cook M; Weiner HL; Wahl SM
J Immunol; 1998 Dec; 161(11):6297-304. PubMed ID: 9834119
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
Carl VS; Gautam JK; Comeau LD; Smith MF
J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
12. Interaction of bacterial cell wall polymers and rat macrophages.
Schwab JH; Smialowicz R
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):283-8. PubMed ID: 126561
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum.
Yoon YD; Han SB; Kang JS; Lee CW; Park SK; Lee HS; Kang JS; Kim HM
Int Immunopharmacol; 2003 Dec; 3(13-14):1873-82. PubMed ID: 14636836
[TBL] [Abstract][Full Text] [Related]
14. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
15. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
Gabay C; Porter B; Fantuzzi G; Arend WP
J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
[TBL] [Abstract][Full Text] [Related]
16. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha.
Barrios-Rodiles M; Tiraloche G; Chadee K
J Immunol; 1999 Jul; 163(2):963-9. PubMed ID: 10395693
[TBL] [Abstract][Full Text] [Related]
19. Systemic macrophage activation in locally-induced experimental arthritis.
Simon J; Surber R; Kleinstäuber G; Petrow PK; Henzgen S; Kinne RW; Bräuer R
J Autoimmun; 2001 Sep; 17(2):127-36. PubMed ID: 11591121
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
